---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-214569"
form_type: "8-K"
ticker: "CCEL"
cik: "0000862692"
company_name: "CRYO CELL INTERNATIONAL INC"
filed_at: "2026-05-08T23:59:59+00:00"
generated_at: "2026-05-14T21:17:15.893232+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# NYSE American accepts Cryo-Cell compliance plan; trading continues through Sep 2027

## Summary
- Received notice of non-compliance on Mar 12, 2026 for stockholders' deficit and net losses in two of three fiscal years ending Nov 30, 2025.
- Compliance plan accepted May 6, 2026; plan period extends to September 9, 2027 to regain listing standards.
- Common stock remains listed and traded on NYSE American during plan period, subject to periodic review.
- Failure to regain compliance or make progress by deadline could result in delisting proceedings.
- Company reported stockholders' deficit as of Nov 30, 2025 and net losses in FY2023, FY2024, FY2025.

## SEC filing metadata
- accession: 0001193125-26-214569
- form_type: 8-K
- ticker: CCEL
- cik: 0000862692
- company_name: CRYO CELL INTERNATIONAL INC
- filed_at: 2026-05-08T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 3.01, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/862692/000119312526214569/0001193125-26-214569-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/862692/000119312526214569/ccel-20260506.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-214569
- JSON: https://secwatch.observer/filing/0001193125-26-214569.json
- Plain text: https://secwatch.observer/filing/0001193125-26-214569.txt

## Source-grounded claims
- claim_id: 129e84cf0c2c6e11a34ec716fc439494ebe4b31b
  claim: CRYO CELL INTERNATIONAL INC received a nyse_american extension granted notice regarding other.
  evidence_excerpt: May 6, 2026, Cryo-Cell International, Inc. (the "Company”) received a written notice from NYSE Regulation stating that it had accepted the Company’s plan to regain compliance with the continued listing standards of the N
  evidence_url: https://www.sec.gov/Archives/edgar/data/862692/000119312526214569/0001193125-26-214569-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.